A clinical trial for a treatment for the Bundibugyo strain of Ebola has begun in the Democratic Republic of Congo. The trial aims to identify effective treatments for the disease, with patient enrollment underway. It is unclear if the trial has already started or is imminent, as some reports indicate it has begun while others suggest it is due to start soon.